LeypoldtJ., MistryC.Ultrafiltration in peritoneal dialysis. In: GokalR., NolphK., eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994; 135–60.
2.
FerianiM., LaGrecaG., KrigerF., WinchesterJ.CAPD systems and solutions. In: GokalR., NolphK., eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994; 233–70.
3.
BreborowiczA.In vitro study on the peritoneal biocompatibility of the peritoneal dialysis solutions.Perit Dial Int1993; 13(Suppl 2): S105–8.
4.
DobbieJ.W.New concepts in molecular biology and ultrastructural pathology of the peritoneum: Their significance for peritoneal dialysis.Am J Kidney Dis1990; 15: 97–109.
5.
TwardowskiZ.J., KhannaR., NolphE.D.Osmotic agents and ultrafiltration in peritoneal dialysisNephron1986; 42: 93–101.
6.
LindholmB., BergströmJ.Nutritional requirements of peritoneal dialysis. In: GokalR., NolphK.D., eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994; 443–72.
7.
HeatonA., WardM.K., JohnstonD.G., NicholsonD.V., AlbertiKGMM, KerrD.N.S.Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis.Clin Sci1984; 67: 121–130.
8.
LindholmB., WerynskiA., BergströmJ.Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents.ASA/O Trans1987; 33: 19–27.
9.
CheighJ., SerurD., PaguiriganM., StenzelK., RubinA.How well is hypertension controlled in CAPD patients.Adv Perit Dial1994; 10: 55–8.
10.
LameireN., BernaertP., LambertM., VijtD.Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis.Kidney Int1994; 46(Suppl 48): S31–8.
11.
RippeB., StelinG.How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: fact and myth. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1990; 13–8.
12.
RippeB., ZakariaE., CarlssonO.Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?Perit Dial Int1996; 16(Suppl 1): S97–103.
13.
GjessingJ.The use of dextran as a dialysing fluid in peritoneal dialysis.Acta Med Scand1969; 185: 237–9.
14.
TwardowskiZ.J., MooreH.L., McGaryT.J., PoskutaM., HirszelP., StathakisC.Polymers as osmotic agents for peritoneal dialysis.Perit Dial Bull1984; 4(Suppl 3): S125–31.
15.
TwardowskiZ.J., HainH., McGaryT.J., MooreH.L., KellerR.S.Sustained UF with gelatin dialysis solution during long dwell dialysis exchanges in rats. In: MaherJ.F., WinchesterJ.F., eds Frontiers in Peritoneal Dialysis.New York: Field, Rich, 1986; 249–54.
16.
MistryC.D., GokalR.Icodextrin in peritoneal dialysis: early development and clinical use.Perit Dial Int1994; 14(Suppl 2): S13–21.
17.
KleinE., WardR.A., WilliamsT.E., FeldhoffP.W.Peptides as substitute osmotic agents for glucose in peritoneal dialysate.ASA/O Trans1986; 32: 550–3.
18.
MartisL., BurkeR., KleinE.Evaluation of a peptide-based solution for peritoneal dialysis.Perit Dial Int1993; 13(Suppl 2): S92–4.
19.
MistryC.D., GokalR.The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview.Perit Dial Int1994; 14(Suppl 3): S158–61.
20.
MistryC.D., BhowmickB., AshmanR., UttleyL.Clinical studies of new icodextrin formulations.Perit Dial Int1994; 14(Suppl 2): S55–7.
21.
YoungG.A., KoppleJ.D., LindholmB.Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study.Am J Kidney Dis1991; 17: 462–71.
22.
HeimburgerO., LindholmB., BergstromJ.Nutritional effects and nutritional management of chronic peritoneal dialysis. In: KoppleJ., MassryS., eds. Nutritional management of renal disease.Baltimore: Williams & Wilkins, 1996; 619–68.
23.
Canada-USA (CANUSA) Peritoneal Dialysis Study Group.Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcome.J Am Soc Nephrol1996; 7: 198–207.
24.
McCuskerF., TeehanB., ThorpeK., KeshaviahP., ChurchillD.How much peritoneal dialysis is required for the maintenance of a good nutritional state?Kidney Int1996; 50 (Suppl 56): S56–61.
25.
KredietR.T., ImholzA.L.T., LameireN., FaictD., KoomenG.C.M., MartisL.The use of peptides in peritoneal dialysis fluids.Perit Dial Int1994; 14(Suppl 3): S152–7.
MistryC.D., GokalR.Optimal use of glucose polymer (Icodextrin) in peritoneal dialysis.Perit Dial Int1996; 16(Suppl 1): S104–8.
28.
DaviesD.S.Kinetics of icodextrin.Perit Dial Int1994; 14(Suppl 2): S45–50.
29.
ImholzA.L.T., LameireN., FaictD., KoomenG.C.M., KredietR.T., MartisL.Evaluation of short chain polypeptides as osmotic agent in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1994; 14: 215–22.
30.
FallerB., AparicioM., FaictD.Clinical evaluation of an 1.1% amino acid solution.Nephrol Dial Transplant1995; 10: 1432–7.
31.
KoppleJ.D., BernardD., MessanaJ.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 148–57.
32.
JonesM., HamburgerR., CharytanC.Treatment of malnutrition in peritoneal dialysis (PD) patients with a 1.1% amino-acid (AA) dialysis solution (Abstract).Perit Dial Int1995; 15(Suppl 1): S42.
33.
FürstP.New strategies in clinical nutrition.Perit Dial Int1996; 16(Suppl 1): S28–35.
34.
ParkM.S., LeeJ., JooJ.Dipeptide-based solution for peritoneal dialysis: investigations with a rat model.Korea J Nephrol1995; 14: 161–7.
35.
YatzidisH., DombrosN., DigenisG.On the usefulness of glycylglycine inhemodialysis and peritoneal dialysis solution.ASAIO J1996; 42: 984–92.
36.
ParkM.S., HeimburgerO., WaniewskiJ.Experimental peritoneal dialysis using a di-peptide solution in rat (Abstract).Perit Dial Int1993; 13(Suppl 1): S93.
37.
WerynskiA., WaniewskiJ., FürstP., SitarekJ., BergströmJ., LindholmB.Kinetic analysis of peptide (DP) cleavage, amino acid (AA) generation and transport of DP and AA in DP based peritoneal dialysis (PD) in rats (abstract).ASAIO J1997. In press.
38.
YatzidisH.A new stable bicarbonate dialysis solution for peritoneal dialysis: preliminary report.Perit Dial Int1991; 11: 224–7.
39.
YatzidisH.Enhanced ultrafiltration in rabbits with bicarbonate glycylglycine peritoneal dialysis solution.Perit Dial Int1993; 13: 302–6.
